Premium
Anticonvulsant and proconvulsant actions of 2‐deoxy‐ d ‐glucose
Author(s) -
Gasior Maciej,
Yankura Jessica,
Hartman Adam L.,
French Amy,
Rogawski Michael A.
Publication year - 2010
Publication title -
epilepsia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.687
H-Index - 191
eISSN - 1528-1167
pISSN - 0013-9580
DOI - 10.1111/j.1528-1167.2010.02593.x
Subject(s) - seizure threshold , pentylenetetrazol , anticonvulsant , kainic acid , epilepsy , pharmacology , chemistry , carbohydrate metabolism , amygdala , convulsion , endocrinology , medicine , biochemistry , neuroscience , psychology , receptor , glutamate receptor
Summary Purpose: 2‐Deoxy‐ d ‐glucose (2‐DG), a glucose analog that accumulates in cells and interferes with carbohydrate metabolism by inhibiting glycolytic enzymes, has anticonvulsant actions. Recognizing that severe glucose deprivation can induce seizures, we sought to determine whether acute treatment with 2‐DG can promote seizure susceptibility by assessing its effects on seizure threshold. For comparison, we studied 3‐methyl‐glucose (3‐MG), which like 2‐DG accumulates in cells and reduces glucose uptake, but does not inhibit glycolysis. Methods: Mice were treated with 2‐DG or 3‐MG and the seizure threshold determined in the 6‐Hz test, the mouse electroshock seizure threshold (MEST) test, and the intravenous pentylenetetrazol (i.v. PTZ) or kainic acid (i.v. KA) seizure threshold tests. 2‐DG was also tested in fully amygdala‐kindled rats. Results: 2‐DG (125–500 mg/kg, i.p., 30 min before testing) significantly elevated the seizure threshold in the 6‐Hz seizure test. 2‐DG (250–500 mg/kg) decreased the threshold in the MEST and i.v. PTZ and i.v. KA tests. 3‐MG had no effect on seizure threshold in the 6‐Hz test but, like 2‐DG, decreased seizure threshold in the i.v. PTZ test. 2‐DG (250 and 500 mg/kg, i.p., 30 min before testing) had no effect on amygdala‐kindled seizures. Conclusions: Although 2‐DG protects against seizures in the 6‐Hz seizure test, it promotes seizures in some other models. The proconvulsant action may relate to reduced glucose uptake, whereas the anticonvulsant action may require inhibition of glycolysis and shunting of glucose metabolism through the pentose phosphate pathway.